(Q38093850)

28 August 2017

title

Challenges in immunodiagnostic tests for leprosy (English)

1 reference

28 August 2017

0 references

1

Annemieke Geluk

1 reference

28 August 2017

language of work or name

English

0 references

publication date

28 March 2013

1 reference

Expert Opinion on Medical Diagnostics

28 August 2017

published in

1 reference

28 August 2017

volume

7

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

265-274

1 reference

Importance of the neural predilection of Mycobacterium leprae in leprosy

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

The continuing challenges of leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Leprosy now: epidemiology, progress, challenges, and research gaps

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Leprosy and cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Learning from lesions: patterns of tissue inflammation in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Genetics of leprosy reactions: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Leprosy as a genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Segregation of HLA/TNF region is linked to leprosy clinical spectrum in families displaying mixed leprosy subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

HLA-DRB1*04 and DRB1*10 are associated with resistance and susceptibility, respectively, in Brazilian and Vietnamese leprosy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

HLA and leprosy in the pre and postgenomic eras

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Susceptibility to leprosy is associated with PARK2 and PACRG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Stepwise replication identifies a low-producing lymphotoxin-α allele as a major risk factor for early-onset leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Genomewide association study of leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

High rates of undiagnosed leprosy and subclinical infection amongst school children in the Amazon Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Leprosy: diagnostic and control challenges for a worldwide disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Use of protein antigens for early serological diagnosis of leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Vaccines against tuberculosis: where are we and where do we need to go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Learning from leprosy: insight into the human innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Massive gene decay in the leprosy bacillus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

From genome-based in silico predictions to ex vivo verification of leprosy diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Divergence of macrophage phagocytic and antimicrobial programs in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

New pathways of protective and pathological host defense to mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Specific memory within innate immune systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Phagocytosis mediates specificity in the immune defence of an invertebrate, the woodlouse Porcellio scaber (Crustacea: Isopoda).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Six-of-the-best: unique contributions of γδ T cells to immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Macrophage inflammatory protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

The importance of CD11b+ dendritic cells in CD4+ T cell activation in vivo: with help from interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Lateral flow assay for simultaneous detection of cellular- and humoral immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

A user-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Circulating levels of insulin-like growth factor-I (IGF-I) correlate with disease status in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Human immunodeficiency virus and leprosy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Leprosy and HIV coinfection: a clinical, pathological, immunological, and therapeutic study of a cohort from a Brazilian referral center for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Leprosy and HIV coinfection: a critical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Hansen's disease: a vanishing disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Diabetic status of patients with leprosy in Kuwait

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Eliminating latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

A major susceptibility locus for leprosy in India maps to chromosome 10p13

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

Identification of Specific Proteins and Peptides in Mycobacterium leprae Suitable for the Selective Diagnosis of Leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530059.2013.786039

10.1517/17530059.2013.786039

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference